Skip to main content
Equibles

Matthew Lowell

CFO

Alpha Teknova, Inc. (TKNO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alpha Teknova, Inc. publishes a filing, an earnings call transcript or a press release.

Get TKNO alerts

About Matthew Lowell

Matthew Lowell is recorded as CFO at Alpha Teknova, Inc. (TKNO). The newest filing on record that lists Matthew Lowell as CFO at Alpha Teknova, Inc. (TKNO) is dated April 21, 2026. The proxy statement of Alpha Teknova, Inc. reports total compensation of $1,212,052 for Matthew Lowell in fiscal 2021, including a base salary of $302,408. Disclosed compensation is on record for 2 fiscal years. Matthew Lowell has spoken on 9 earnings calls across 1 company, most recently for Alpha Teknova, Inc. on May 13, 2024. Alpha Teknova, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alpha Teknova, Inc. includes Stephen Gunstream (CEO and Board Member), Damon Terrill (General Counsel), Brett Robertson (Board Member) and 3 others.

Matthew Lowell on recent calls

“Results for the first quarter of 2024 from a revenue perspective were similar to the first quarter of the prior year, but an 18% increase sequentially. Overall, we delivered solid financial results for the first quarter 2024.”
CFO, Alpha Teknova, Inc. Q1 FY2024 Earnings Call ·
“Results for the fourth quarter of 2023 from a revenue perspective were similar to prior year as anticipated given ongoing challenges in our markets over the past year.”
CFO, Alpha Teknova, Inc. Q4 FY2023 Earnings Call ·
“Starting with revenue, total revenue was $8.2 million for the third quarter of 2023. A 24% decline from $10.7 million in the third quarter of 2022. Excluding two large non-biotech customer deliveries in the third quarter of 2022, underlying growth was approximately 5%.”
CFO, Alpha Teknova, Inc. Q3 FY2023 Earnings Call ·
“Total revenue was $11.5 million for the second quarter of 2023, a slight decline from $11.7 million in the second quarter of 2022, reflecting the continued headwinds associated with lower demand from early-stage biopharma customers, but partially offset by delivery of a large order to a significant customer during the…”
CFO, Alpha Teknova, Inc. Q2 FY2023 Earnings Call ·
“Total revenue was $9.1 million for the first quarter of 2023, an 18% decline from $11.1 million in the first quarter of 2022, reflecting the continued headwinds associated with lower demand from early-stage biopharma customers, which we first observed in the third quarter of 2022.”
CFO, Alpha Teknova, Inc. Q1 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Alpha Teknova, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Alpha Teknova, Inc. (TKNO) $302,408 $1,212,052
2020 Alpha Teknova, Inc. (TKNO) — —

Recent activity